Article
Imaging of CNS myelin by positron-emission tomography
5 Jun 2006
Abstract excerpt
Promoting myelin repair is one of the most promising therapeutic avenues in the field of myelin disorders. In future clinical trials, evaluation of remyelination will require a reliable and quantifiable myelin marker to be used as a surrogate marker. To date, MRI assessment lacks specificity for evaluating the level of remyelination within the brain. Here, we describe 1,4-bis(p-aminostyryl)-2-methoxy benzene...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
